Literature DB >> 11154736

NAD(P)H:quinone oxidoreductase 1 (NQO1): chemoprotection, bioactivation, gene regulation and genetic polymorphisms.

D Ross1, J K Kepa, S L Winski, H D Beall, A Anwar, D Siegel.   

Abstract

NAD(P)H:quinone oxidoreductase 1 (NQO1) is an obligate two-electron reductase that is involved in chemoprotection and can also bioactivate certain antitumor quinones. This review focuses on detoxification reactions catalyzed by NQO1 and its role in antioxidant defense via the generation of antioxidant forms of ubiquinone and vitamin E. Bioactivation reactions catalyzed by NQO1 are also summarized and the development of new antitumor agents for the therapy of solid tumors with marked NQO1 content is reviewed. NQO1 gene regulation and the role of the antioxidant response element and the xenobiotic response element in transcriptional regulation is summarized. An overview of genetic polymorphisms in NQO1 is presented and biological significance for chemoprotection, cancer susceptibility and antitumor drug action is discussed.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11154736     DOI: 10.1016/s0009-2797(00)00199-x

Source DB:  PubMed          Journal:  Chem Biol Interact        ISSN: 0009-2797            Impact factor:   5.192


  169 in total

1.  FQR1, a novel primary auxin-response gene, encodes a flavin mononucleotide-binding quinone reductase.

Authors:  Marta J Laskowski; Kate A Dreher; Mary A Gehring; Steffen Abel; Arminda L Gensler; Ian M Sussex
Journal:  Plant Physiol       Date:  2002-02       Impact factor: 8.340

Review 2.  System review and metaanalysis of the relationships between five metabolic gene polymorphisms and colorectal adenoma risk.

Authors:  Zhi-Qiang Zhao; Qing-Kai Guan; Fei-Yun Yang; Peng Zhao; Bing Zhou; Zhi-Jun Chen
Journal:  Tumour Biol       Date:  2011-12-13

3.  Induction of NAD(P)H-quinone oxidoreductase 1 by antioxidants in female ACI rats is associated with decrease in oxidative DNA damage and inhibition of estrogen-induced breast cancer.

Authors:  Bhupendra Singh; Nimee K Bhat; Hari K Bhat
Journal:  Carcinogenesis       Date:  2011-11-09       Impact factor: 4.944

Review 4.  Cytochrome P450 humanised mice.

Authors:  Frank J Gonzalez
Journal:  Hum Genomics       Date:  2004-05       Impact factor: 4.639

Review 5.  Gene-environment interactions in asthma.

Authors:  S McLeish; S W Turner
Journal:  Arch Dis Child       Date:  2007-11       Impact factor: 3.791

6.  Metabolic enzyme considerations in cancer therapy.

Authors:  Amit K Jain; Sweta Jain; A C Rana
Journal:  Malays J Med Sci       Date:  2007-01

7.  Leflunomide induces NAD(P)H quinone dehydrogenase 1 enzyme via the aryl hydrocarbon receptor in neonatal mice.

Authors:  Amrit Kumar Shrestha; Ananddeep Patel; Renuka T Menon; Weiwu Jiang; Lihua Wang; Bhagavatula Moorthy; Binoy Shivanna
Journal:  Biochem Biophys Res Commun       Date:  2017-02-10       Impact factor: 3.575

8.  Disruption of NAD(P)H:quinone oxidoreductase 1 gene in mice leads to 20S proteasomal degradation of p63 resulting in thinning of epithelium and chemical-induced skin cancer.

Authors:  B A Patrick; X Gong; A K Jaiswal
Journal:  Oncogene       Date:  2010-11-01       Impact factor: 9.867

9.  Risk analysis of severe myelotoxicity with temozolomide: the effects of clinical and genetic factors.

Authors:  Terri S Armstrong; Yumei Cao; Michael E Scheurer; Elizabeth Vera-Bolaños; Rochelle Manning; Mehmet F Okcu; Melissa Bondy; Renke Zhou; Mark R Gilbert
Journal:  Neuro Oncol       Date:  2009-12       Impact factor: 12.300

10.  Genetic polymorphisms of NQO1, CYP1A1 and TPMT and susceptibility to acute lymphoblastic leukemia in a Tunisian population.

Authors:  Slah Ouerhani; Nouha Cherif; Ikbel Bahri; Ines Safra; Samia Menif; Salem Abbes
Journal:  Mol Biol Rep       Date:  2012-10-14       Impact factor: 2.316

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.